Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the Solid Tumor Advanced Panel by NGS is typically 14-21 days.

What are the prerequisites for the test Solid Tumor Advanced Panel by NGS

  • Patient must have a confirmed diagnosis of solid tumor
  • Physician order for the Solid Tumor Advanced Panel by NGS
  • Specimen type: FFPE tissue block or 10 unstained slides with at least 20% tumor content
  • Specimen stability: FFPE blocks stored at room temperature for up to 5 years, unstained slides stored at room temperature for up to 6 months
  • Specimen collection: Specimen must be collected and handled according to standard operating procedures to avoid contamination

What are the measure values for the test Solid Tumor Advanced Panel by NGS

  • EGFR - Exon 18, 19, 20, 21: 0-100%
  • KRAS - Codon 12, 13, 59, 61, 117 and 146: 0-100%
  • BRAF - Codon 600: 0-100%
  • PIK3CA - Exon 9, 20: 0-100%
  • ERBB2 - Exon 20: 0-100%

What does this test Solid Tumor Advanced Panel by NGS identify?

  • The Solid Tumor Advanced Panel by NGS identifies specific genetic mutations and alterations in solid tumors.
  • It can detect mutations in genes such as EGFR, KRAS, BRAF, and TP53, which are commonly associated with various types of cancer.
  • The panel can also identify copy number variations and gene fusions that may be driving tumor growth.
  • By analyzing a comprehensive set of genes, the test provides valuable information for personalized treatment strategies, prognosis, and monitoring of disease progression.
  • Overall, the Solid Tumor Advanced Panel by NGS helps oncologists make informed decisions about targeted therapies and clinical management of cancer patients.

Why is this test Solid Tumor Advanced Panel by NGS taken?

The Solid Tumor Advanced Panel by NGS test is taken to provide comprehensive genetic information about solid tumors, such as lung cancer, breast cancer, colorectal cancer, and others. This test uses Next-Generation Sequencing (NGS) technology to analyze multiple genes simultaneously, allowing for the detection of various genetic mutations that may be driving the growth of the tumor.

By identifying specific genetic alterations, healthcare providers can tailor treatment plans to target the underlying molecular drivers of the tumor. This personalized approach to cancer treatment can improve patient outcomes and reduce the likelihood of adverse effects from ineffective treatments.

Furthermore, the Solid Tumor Advanced Panel by NGS test can also provide information on potential drug resistance mutations, allowing healthcare providers to anticipate and address resistance to certain therapies.

No FAQs available.

Customer Google Rating